Financial Statements 2 investments Shares in subsidiary undertakings m Cost: At 1 January 2014 14,729 Additions during the year 554 Demerger of subsidiary during the year 509 At 31 december 2014 14,774 Provision for impairment: At 1 January 2014 Provided for during the year At 31 december 2014 Net book amounts: At 1 January 2014 14,729 At 31 december 2014 14,774 The Directors believe that the carrying value of the investments is supported by their underlying net assets.
During the year, as part of the internal reorganisation, Reckitt Benckiser Pharmaceuticals Inc. was made a direct investment of Reckitt Benckiser Group plc prior to demerger.
Principal Subsidiary Undertakings The principal subsidiary undertakings as at 31 December 2014, all of which are included in the consolidated financial statements, are shown below.
Country of incorporation or registration and Effective % of share Product category operation capital held by the Group Reckitt Benckiser plc holding company UK Ordinary 100 Reckitt Benckiser Australia Pty Limited health, hygiene, home Australia Ordinary 100 Reckitt Benckiser Brasil Limitada health, hygiene, home Brazil Ordinary 100 Reckitt Benckiser Canada Inc. health, hygiene, home and Food Canada Ordinary 100 Reckitt Benckiser Deutschland GmbH health, hygiene, home Germany Ordinary 100 Reckitt Benckiser Espaa SL health, hygiene, home Spain Ordinary 100 Reckitt Benckiser France SAS health, hygiene, home France Ordinary 100 Reckitt Benckiser Healthcare UK Limited health, hygiene, home UK Ordinary 100 Reckitt Benckiser LLC health, hygiene, home and Food US Ordinary 100 Reckitt Benckiser India Limited health, hygiene, home India Ordinary 100 Reckitt Benckiser Italia SpA health, hygiene, home Italy Ordinary 100 Reckitt Benckiser Arabia FZE health, hygiene, home UAE Dubai Ordinary 100 Schiff Nutrition International, Inc. health US Ordinary 100 With the exception of Reckitt Benckiser plc, none of the above subsidiaries are held directly by Reckitt Benckiser Group plc.
All subsidiaries have a financial year ending 31 December with the exception of Reckitt Benckiser India Limited which has a year ending 31 March.
The principal subsidiary undertakings as at 31 December 2013 also included Reckitt Benckiser Pharmaceuticals Inc. which was included in the demerger of the pharmaceutical business.
Refer to note 27 of the Group financial statements for further details.
As permitted by s. 410 of the Companies Act 2006, particulars of other subsidiary undertakings are not shown above.
A full list of the Companys subsidiary undertakings will be annexed to the Companys annual return to Companies House.
3 debtors due Within one year 2014 2013 m m Amounts owed by Group undertakings 131 70 Amounts owed by Group undertakings are unsecured, interest free and are repayable on demand.
RB Annual Report and Financial Statements 2014 121
